Skip to main content
Premium Trial:

Request an Annual Quote

Counsyl Raises $80M

NEW YORK (GenomeWeb) – Genetic testing firm Counsyl reported today that it has raised $80 million in financing from life sciences investment firm Perceptive Advisors.

Counsyl Cofounder and CEO Ramji Srinivasan said in a statement that the new financing will be used to grow the company "with an eye toward making expanded carrier screening as routine as taking folic acid, noninvasive prenatal screening as routine as an ultrasound, and hereditary cancer screening as well-known as a pap smear."

The firm offers tests such as Foresight Carrier Screen, Prelude Prenatal Screen, and Reliant Cancer Screen. Since its founding, Counsyl has screened more than 850,000 patients, served more than 17,000 healthcare providers, and provided more than 60,000 genetic counseling sessions, it noted.

The company previously raised $28 million in 2014. According to Counsyl's website, the firm had previously raised a total of $102 million. 

The company also announced today that Home Care Assistance CEO Lily Sarafan has joined Counsyl's board.

The Scan

Study Reveals New Details About Genetics of Major Cause of Female Infertility

Researchers in Nature Medicine conducted a whole-exome sequencing study of mote than a thousand patients with premature ovarian insufficiency.

Circulating Tumor DNA Shows Potential as Biomarker in Rare Childhood Cancer

A study in the Journal of Clinical Oncology has found that circulating tumor DNA levels in rhabdomyosarcoma may serve as a biomarker for prognosis.

Study Recommends Cancer Screening for Dogs Beginning Age Seven, Depending on Breed

PetDx researchers report in PLOS One that annual cancer screening for dogs should begin by age seven.

White-Tailed Deer Harbor SARS-CoV-2 Variants No Longer Infecting Humans, Study Finds

A new study in PNAS has found that white-tailed deer could act as a reservoir of SARS-CoV-2 variants no longer found among humans.